We have a passion for Idiopathic Pulmonary Fibrosis research. Idiopathic Pulmonary Fibrosis is a serious condition which represents a large unmet medical need. Pacific Immuna CelKem specializes in proteins and genes related to the immune response pathways involved in pulmonary fibrosis.
In order to fund this research Pacific Immuna Celkem provides reagents, contract research services, and consumables for research, analysis, discovery, and diagnostics.
We are building out biomolecule reagents for sale, biomolecular assay kits, and imaging products. We are designing scientific equipment, software and instruments to improve the research flow at the bench.
The Northwest is home to some of the best talent IPF research. Our goal to provide the best biomolecular molecules, and to develop models that meet the research need.
Idiopathic Pulmonary Fibrosis is a serious condition which represents a large unmet medical need. Once diagnosed with the disease the life expectancy for most is only a few years.
A protein science company located in the Pacific Northwest, Pacific Immuna CelKem specializes in proteins and genes related to the immune response pathways involved in pulmonary fibrosis.
Now part of the RAIN Incubator Tacoma. To educate our community and grow jobs, talent, and companies in BioTech for Tacoma.
Graduate from Eastern Washington University in Biochemistry - Biotechnology Program. Four years at the Hutch in Nephrology. Twenty years at AMGEN IMMUNEX specializing in the purification and formulation of biologics and protein reagents from various cell lines in support of AMGEN research groups. Handled molecules surrounding the therapeutic target including the target for antigen or SAR. Specialized in the purification development for large scale rodent and cyno surrogate IgG2 purifications. This included many forms of chromatography and various solutions. Gained experience and expertise in targets for small molecule enzymology from Baculo and mammalian hosts.
Process Development in the separation development of non-tagged biologics by conventional media techniques. Focused on the early biologic therapeutic for pre PK / tox studies and the surrogate protein counterpart. Modalities included soluble receptors/ligands, Fc fusion therapy, antibody protein, and enzyme proteins. The scale ranged from 1 – 100L fermentation in various host cell lines. I worked to provided formulation strategies in meeting a goal of clean products with the lowest possible level of aggregate and host contaminants. The process strategies were transferred to the engineering colleagues to take the molecule to clinic.
Chris is a Seattle University graduate with a passion for biotechnology. Senior research associate aiding in the production of proteins. His laboratory career began as a Clinical Laboratory Specialist, specializing in the screening of blood products for human leukocyte antigens using qualitative ELISA processing instruments. He also performed nucleic acid testing to check for the presence of West Nile Virus, Zika Virus, HIV, HCV, and HBV within human DNA.